Detalhe da pesquisa
1.
Shifting trends and sicker patients: Reassessing hysterectomy performed for benign indications by gynecologic oncologists.
Gynecol Oncol
; 184: 43-50, 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38277920
2.
Dedicated financial hardship screening adds value to routine distress screening among gynecologic cancer patients.
Gynecol Oncol
; 183: 53-60, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38518528
3.
2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023.
J Low Genit Tract Dis
; 28(1): 3-6, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38117563
4.
Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(5): 468-482, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37080223
5.
Doubling down on the future of gynecologic oncology: The SGO future of the profession summit report.
Gynecol Oncol
; 171: 76-82, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36827841
6.
Moderate to severe distress in half of ovarian cancer patients undergoing treatment highlights a need for more proactive symptom and psychosocial management.
Gynecol Oncol
; 166(3): 503-507, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35778291
7.
Navigating job and cancer demands during treatment: A qualitative study of ovarian cancer patients.
Gynecol Oncol
; 166(3): 481-486, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35902296
8.
Clinical outcomes in patients with COVID-19 and gynecologic cancer: A society of gynecologic oncology COVID-19 and gynecologic cancer registry study.
Gynecol Oncol
; 167(2): 146-151, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36154761
9.
Feasibility, Safety, and Provider Perspectives of Bipolar Electrosurgical Cautery Device for (Opportunistic or Complete) Salpingectomy at the Time of Cesarean Delivery.
Am J Perinatol
; 2022 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35728603
10.
Total and out-of-pocket costs for PARP inhibitors among insured ovarian cancer patients.
Gynecol Oncol
; 160(3): 793-799, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33375989
11.
The financial burden of PARP inhibitors on patients, payors, and financial assistance programs: Who bears the cost?
Gynecol Oncol
; 160(3): 800-804, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33414026
12.
Systematic Next Generation Sequencing is feasible in clinical practice and identifies opportunities for targeted therapy in women with uterine cancer: Results from a prospective cohort study.
Gynecol Oncol
; 163(1): 85-92, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34372972
13.
Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis.
Gynecol Oncol
; 162(3): 532-538, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34217544
14.
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021.
J Natl Compr Canc Netw
; 19(8): 888-895, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34416706
15.
A batch-effect adjusted Simon's two-stage design for cancer vaccine clinical studies.
Biometrics
; 77(3): 1075-1088, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32822525
16.
Evaluating meaningful levels of financial toxicity in gynecologic cancers.
Int J Gynecol Cancer
; 31(6): 801-806, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33858954
17.
Fluorescence Imaging of the Ureter in Minimally Invasive Pelvic Surgery.
J Minim Invasive Gynecol
; 28(2): 332-341.e14, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32615331
18.
Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki-67 dual-stained cytology-Retrospective insights from ATHENA.
Int J Cancer
; 146(9): 2599-2607, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31490545
19.
Human papillomavirus vaccination: Ongoing challenges and future directions.
Gynecol Oncol
; 156(2): 498-502, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31848025
20.
Risk of second primary cancers among survivors of gynecological cancers.
Gynecol Oncol
; 158(3): 719-726, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32616403